Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

NEXI-001

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

NexImmune

Drug class:

Wilms tumor 1 inhibitor, PRAME inhibitor, CD8 T-cell agonist, INCA inhibitor

Related drugs:

‹

›